| Video
Dr. Zacharoff examines the roles of both prescription and illicit opioids—heroin and fentanyl—as components of today’s “opioid abuse epidemic”. There are similarities and important differences and the task for clinicians is to minimize harms while addressing the needs of patients in pain.
| Video
Failing to adequately differentially diagnose the cause of back pain can account for the frequency of clinical failures in treatment. Dr. Glick offers some pointers involving physical assessment, imaging studies, and the impact of failed treatments on the diagnosis. It’s important that primary care...
| Video
Since the Roman Empire, electricity has been used in the field of medicine for treating pain. In the era of modern medicine, the field of neuromodulation has entered its renaissance with the introduction of novel wave forms such as HF10, burst closed loop, and noninvasive vagal nerve stimulation...
| Video
Buprenorphine is an increasingly popular alternative to long term opioid use, with a lower risk profile. But how to safely manage acute pain episodes in patients who are receiving buprenorphine therapy? Clinical pharmacy specialists Foy and Uritsky discuss…
| Video
To quote a contemporary leader in pain care, “Treating pain is a team sport.” Although our healthcare system is still disjointed, causing many clinicians to operate in what may feel like a lonely silo, we can support each other and bolster our patients’ confidence in their prognosis by communicating...
| Video
Clinical pharmacist Mark Garofoli offers a strategic thought process for appropriate selection of medications for patients with muscle spasm and/or muscle spasticity.
| Video
There’s room for improvement in treating fibromyalgia and widespread pain, and new advances in research may take us there. Rheumatologist Roland Staud, MD, FACP, advocates for a comprehensive approach that includes consideration of the patient’s mood, sleep disorders, and fatigue, and emphasizes non...
| Video
Headaches, of all varieties, are a common occurrence in adult and pediatric populations. What’s the distinction between types, and how best can practitioners make that distinction? Dr. VanderPluym of the Mayo Clinic, a pediatric neurologist specializing in headache and concussion, discusses.
| Video
>Empathy is the ability to understand the patient’s experience from their frame of reference. Dr. Zacharoff discusses how taking the patient’s narrative into account can result in a more rewarding and successful level of patient-provider communication and lead to better treatment outcomes.
| Video
While abuse deterrent formulations purportedly meet the FDA demand for safer opioid medications, their expense has been rarely supported by third party payors. Dr. Schatman reviews the reimbursement picture, the evidence for their effectiveness, and how prescribers can best respond.